California State Board of Pharmacy Intends to Enter the Food and Drug Administration’s Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products

By Steven Funk On April 29-30, 2021, the California Board of Pharmacy (Board) held a meeting [Agenda Item XI(b–c)], where the Board expressed its intention to sign the Food and Drug Administration’s (FDA) Memorandum of Understanding Addressing Certain Distributions of Continue reading

Medical Board of California Endorses Legislation Allowing Pharmacists to Administer Potential COVID-19 Vaccines Without Federal-Level Approval

By Jonathan Padua At its August 13, 2020 meeting, the Medical Board of California (MBC), in anticipation of a potential COVID-19 vaccine becoming available to the general public, voted to support AB 1710 (Wood) (Chapter 123, September 24, 2020) a Continue reading

California Department of Insurance is Potentially Impacted by Package of Bills Which Propose Additional Medical Insurance Coverage Requirements for Mental Health and Substance Abuse Treatment

By Brittany Hodgson On January 14, 2020, California Senators introduced two bills, both sponsored by the Kennedy Forum and Steinberg Institute, aimed at improving patient access to mental health and substance use disorder treatment: SB 854 (Beall), as introduced, would Continue reading